Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 173

The DOI matches its Crossref record.

Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers

Open access
Ouellet*, Daniele, Hsu, Ann, Qian, Jiang, Locke, Charles S., Eason, Carolyn J., Cavanaugh, John H., Leonard, John M., Granneman, G. Richard · 1998 · British Journal of Clinical Pharmacology

Abstract

Aims To assess the effects of the protease inhibitor ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers. Methods This was an open‐label, single centre study in 23 subjects who received two single doses of oral contraceptive containing 50 μg ethinyl oestradiol on Day 1 (alone) and on Day 29 during concomitant ritonavir. Each subject received 16 days of every 12 h doses of ritonavir from Day 15 through Day 30. Blood samples were collected for serum ethinyl oestradiol concentrations for 48 h after each dose and for plasma ritonavir on Day 29 at 0 and 4 h postdose. Results Statistically significant decreases in ethinyl oestradiol mean Cmax(−32%) and mean AUC (−41%), and a statistically significant increase in the mean terminal elimination rate constant (+31%) were observed during concomitant ritonavir. The harmonic mean terminal half‐life decreased from 17 h to 13 h during concomitant ritonavir. No statistically significant change was noted in tmax. The ratios of means (95% confidence intervals) for Cmax and AUC were 0.682 (0.612–0.758) and 0.595 (0.506–0.694), respectively. The changes in ethinyl oestradiol pharmacokinetics were consistent with an increase in clearance from enzymatic induction of glucuronidation and/or cytochrome P450 hydroxylation. Mean steady‐state ritonavir concentrations of 6.5 and 13.4 μg ml−1 were observed at 0 and 4 h postdose, respectively. Conclusions Considering the extent of the decrease in ethinyl oestradiol concentrations, the use of alternate contraceptive measures should be considered when ritonavir is being administered.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2125.1998.00749.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 173

Metadata

Authors
Ouellet*, D., Hsu, A., Qian, J., Locke, C. S., Eason, C. J., Cavanaugh, J. H., Leonard, J. M., & Granneman, G. R.
Venue
British Journal of Clinical Pharmacology
Publisher
Wiley
Published
1998-08
Volume
46
Issue
2
Pages
111-116
ISSN
  • 0306-5251 (ISSN-L)
  • 1365-2125
OpenAlex
W1566726772
Cited by
173
References
0
FWCI
6.38
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers. https://app.cochat.ai/papers/10.1046/j.1365-2125.1998.00749.x
The paper
Ouellet*, D., Hsu, A., Qian, J., Locke, C. S., Eason, C. J., Cavanaugh, J. H., Leonard, J. M., & Granneman, G. R. (1998). Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers. British Journal of Clinical Pharmacology. https://doi.org/10.1046/j.1365-2125.1998.00749.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.